251 related articles for article (PubMed ID: 19519746)
1. Antifungal activity, mechanism and QSAR studies on chalcones.
Sivakumar PM; Muthu Kumar T; Doble M
Chem Biol Drug Des; 2009 Jul; 74(1):68-79. PubMed ID: 19519746
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents.
Sivakumar PM; Priya S; Doble M
Chem Biol Drug Des; 2009 Apr; 73(4):403-15. PubMed ID: 19291103
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones.
Boeck P; Leal PC; Yunes RA; Filho VC; López S; Sortino M; Escalante A; Furlán RL; Zacchino S
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):87-95. PubMed ID: 15799012
[TBL] [Abstract][Full Text] [Related]
4. Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
Batovska D; Parushev S; Slavova A; Bankova V; Tsvetkova I; Ninova M; Najdenski H
Eur J Med Chem; 2007 Jan; 42(1):87-92. PubMed ID: 17007965
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of chalcones: a mechanistic study using various yeast strains.
Lahtchev KL; Batovska DI; Parushev SP; Ubiyvovk VM; Sibirny AA
Eur J Med Chem; 2008 Oct; 43(10):2220-8. PubMed ID: 18280009
[TBL] [Abstract][Full Text] [Related]
6. Thermal solvent-free synthesis of chromonyl chalcones, pyrazolines and their in vitro antibacterial, antifungal activities.
Siddiqui ZN; Praveen S; Musthafa TN; Ahmad A; Khan AU
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):84-91. PubMed ID: 21612378
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity and QSAR of chalcones against biofilm-producing bacteria isolated from marine waters.
Sivakumar PM; Prabhawathi V; Doble M
SAR QSAR Environ Res; 2010 Apr; 21(3-4):247-63. PubMed ID: 20544550
[TBL] [Abstract][Full Text] [Related]
8. QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds.
Katritzky AR; Slavov SH; Dobchev DA; Karelson M
Bioorg Med Chem; 2008 Jul; 16(14):7055-69. PubMed ID: 18550376
[TBL] [Abstract][Full Text] [Related]
9. The development of 3D-QSAR study and recursive partitioning of heterocyclic quinone derivatives with antifungal activity.
Choi SY; Shin JH; Ryu CK; Nam KY; No KT; Park Choo HY
Bioorg Med Chem; 2006 Mar; 14(5):1608-17. PubMed ID: 16263301
[TBL] [Abstract][Full Text] [Related]
10. Experimental and QSAR of acetophenones as antibacterial agents.
Sivakumar PM; Sheshayan G; Doble M
Chem Biol Drug Des; 2008 Oct; 72(4):303-13. PubMed ID: 18844677
[TBL] [Abstract][Full Text] [Related]
11. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents.
Sivakumar PM; Ganesan S; Veluchamy P; Doble M
Chem Biol Drug Des; 2010 Nov; 76(5):407-11. PubMed ID: 20925692
[TBL] [Abstract][Full Text] [Related]
12. Microwave synthesis and antifungal evaluations of some chalcones and their derived diaryl-cyclohexenones.
Shakil NA; Singh MK; Kumar J; Sathiyendiran M; Kumar G; Singh MK; Pandey RP; Pandey A; Parmar VS
J Environ Sci Health B; 2010 Aug; 45(6):524-30. PubMed ID: 20574873
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antifungal activity and QSAR study of 2-arylhydroxynitroindoles.
Kokurkina GV; Dutov MD; Shevelev SA; Popkov SV; Zakharov AV; Poroikov VV
Eur J Med Chem; 2011 Sep; 46(9):4374-82. PubMed ID: 21802177
[TBL] [Abstract][Full Text] [Related]
14. QSAR Studies on antiepileptic and locomotor in vivo activities of 4,5-diphenyl-1H-imidazoles.
Puratchikody A; Doble M
Chem Biol Drug Des; 2009 Aug; 74(2):173-82. PubMed ID: 19549087
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationships study of a series of imidazole derivatives as potential new antifungal drugs.
Wiktorowicz W; Markuszewsk- M; Krysiński J; Kaliszan R
Acta Pol Pharm; 2002; 59(4):295-306. PubMed ID: 12403305
[TBL] [Abstract][Full Text] [Related]
16. QSAR analysis for heterocyclic antifungals.
Duchowicz PR; Vitale MG; Castro EA; Fernández M; Caballero J
Bioorg Med Chem; 2007 Apr; 15(7):2680-9. PubMed ID: 17296301
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel 3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as antifungal agents.
Sangshetti JN; Nagawade RR; Shinde DB
Bioorg Med Chem Lett; 2009 Jul; 19(13):3564-7. PubMed ID: 19464891
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, physicochemical properties and antimicrobial evaluation of new (E)-chalcones.
Nowakowska Z; Kedzia B; Schroeder G
Eur J Med Chem; 2008 Apr; 43(4):707-13. PubMed ID: 17618710
[TBL] [Abstract][Full Text] [Related]
19. QSARs of some novel isosteric heterocyclics with antifungal activity.
Yalçin I; Oren I; Temiz O; Sener EA
Acta Biochim Pol; 2000; 47(2):481-6. PubMed ID: 11051213
[TBL] [Abstract][Full Text] [Related]
20. DFT-based QSAR models to predict the antimycobacterial activity of chalcones.
Barua N; Sarmah P; Hussain I; Deka RC; Buragohain AK
Chem Biol Drug Des; 2012 Apr; 79(4):553-9. PubMed ID: 22151277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
